Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.985
+0.165 (9.07%)
Mar 9, 2026, 3:38 PM EDT - Market open
Caribou Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Revenue | 11.16 | 9.99 | 34.48 | 13.85 | 9.6 | Upgrade
|
| Revenue Growth (YoY) | 11.66% | -71.01% | 148.91% | 44.31% | -22.35% | Upgrade
|
| Cost of Revenue | - | 129.55 | 112.08 | 82.23 | 52.26 | Upgrade
|
| Gross Profit | 11.16 | -119.56 | -77.6 | -68.38 | -42.66 | Upgrade
|
| Selling, General & Admin | 37.91 | 42.56 | 38.46 | 38.02 | 24.32 | Upgrade
|
| Research & Development | 109.44 | - | - | - | - | Upgrade
|
| Operating Expenses | 147.35 | 42.56 | 38.46 | 38.02 | 24.32 | Upgrade
|
| Operating Income | -136.19 | -162.12 | -116.06 | -106.4 | -66.98 | Upgrade
|
| Interest & Investment Income | - | 15.3 | 15.3 | - | - | Upgrade
|
| Earnings From Equity Investments | -9.16 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 8.83 | 2.2 | -1.12 | 7.18 | -1.21 | Upgrade
|
| EBT Excluding Unusual Items | -136.53 | -144.61 | -101.88 | -99.22 | -68.19 | Upgrade
|
| Merger & Restructuring Charges | - | -0.6 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -0.13 | - | Upgrade
|
| Asset Writedown | -12.15 | - | - | - | - | Upgrade
|
| Legal Settlements | - | -3.9 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 1.58 | Upgrade
|
| Pretax Income | -148.68 | -149.11 | -101.88 | -99.35 | -66.6 | Upgrade
|
| Income Tax Expense | -0.55 | -0.01 | 0.19 | 0.07 | 0.32 | Upgrade
|
| Net Income | -148.13 | -149.11 | -102.07 | -99.42 | -66.92 | Upgrade
|
| Net Income to Common | -148.13 | -149.11 | -102.07 | -99.42 | -66.92 | Upgrade
|
| Shares Outstanding (Basic) | 93 | 90 | 74 | 61 | 32 | Upgrade
|
| Shares Outstanding (Diluted) | 93 | 90 | 74 | 61 | 32 | Upgrade
|
| Shares Change (YoY) | 3.40% | 22.37% | 21.39% | 92.02% | 270.47% | Upgrade
|
| EPS (Basic) | -1.59 | -1.65 | -1.38 | -1.64 | -2.11 | Upgrade
|
| EPS (Diluted) | -1.59 | -1.65 | -1.38 | -1.64 | -2.11 | Upgrade
|
| Free Cash Flow | -112.35 | -143.08 | -104.9 | -97.42 | -34.64 | Upgrade
|
| Free Cash Flow Per Share | -1.20 | -1.58 | -1.42 | -1.60 | -1.09 | Upgrade
|
| Gross Margin | 100.00% | - | -225.07% | - | - | Upgrade
|
| Operating Margin | -1220.49% | -1622.13% | -336.63% | -768.17% | -697.84% | Upgrade
|
| Profit Margin | -1327.40% | -1491.94% | -296.05% | -717.79% | -697.26% | Upgrade
|
| Free Cash Flow Margin | -1006.82% | -1431.66% | -304.27% | -703.34% | -360.91% | Upgrade
|
| EBITDA | -132.55 | -158.19 | -112.53 | -104.78 | -66 | Upgrade
|
| D&A For EBITDA | 3.65 | 3.93 | 3.53 | 1.62 | 0.98 | Upgrade
|
| EBIT | -136.19 | -162.12 | -116.06 | -106.4 | -66.98 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.